genOway S.A.
ALGEN.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -15.4% | 6% | -0% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 0% | 68.9% | 64.5% | 179.2% |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 4% | 3.9% | 3.1% | 53.3% |
| Net Income | €0 | €0 | €0 | €0 |
| % Margin | 1.5% | 9.9% | 6.6% | 5.1% |
| EPS Diluted | 0.015 | 0.11 | 0.076 | 0.062 |
| % Growth | -86.8% | 44.5% | 22.3% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | €0 | €0 | -€0 | €0 |
| Free Cash Flow | €0 | €0 | €0 | €0 |